Europe Epilepsy Devices Market Forecast 2022-2030
Description
Europe Epilepsy Devices Market Forecast 2022-2030
KEY FINDINGS
The Europe epilepsy devices market is anticipated to grow with a 7.61% CAGR during the estimated period 2022-2030. The technological advancements in therapeutic devices, the growing geriatric population prone to epilepsy, and reimbursement availability drive the Europe market growth.
MARKET INSIGHTS
The Europe epilepsy devices market growth evaluation entails an assessment of Germany, Italy, Nordic Countries, Spain, United Kingdom, France, and Rest of Europe. Geographic and socioeconomic factors may impact epilepsy prevalence. The Nordic nations are not only close geographically, but they also have a lot of similarities in their cultures, standards of living, and economy. Publicly subsidized, all-encompassing healthcare systems protect the Nordic region’s whole resident population. The resultant ever-growing aging population, early detection and diagnosis of epilepsy among the population, and various medical therapies have increased the market for epilepsy devices in Nordic Countries.
In Spain, epilepsy affects more than 4,000 children annually. Refractory epilepsy, or epilepsy that does not respond to medication, affects one in three people. Drug-resistant forms of epilepsy place a heavy strain on patients and their families. With recurring crises, underlying neurological conditions, medication side effects, and societal stigmatization, patients present major medical and social problems.
As a result, epilepsy treatments involving vagus nerve stimulation, deep brain stimulation, accelerometer, and neurostimulation will gain popularity throughout the anticipated period. Spain is also aiming to develop modern healthcare systems that will make available more affordable and effective solutions for the general people, increasing demand for epilepsy equipment.
COMPETITIVE INSIGHTS
Some of the key players include Philips NV, LivaNova PLC, NeuroPace Inc, Nihon Kohden Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
KEY FINDINGS
The Europe epilepsy devices market is anticipated to grow with a 7.61% CAGR during the estimated period 2022-2030. The technological advancements in therapeutic devices, the growing geriatric population prone to epilepsy, and reimbursement availability drive the Europe market growth.
MARKET INSIGHTS
The Europe epilepsy devices market growth evaluation entails an assessment of Germany, Italy, Nordic Countries, Spain, United Kingdom, France, and Rest of Europe. Geographic and socioeconomic factors may impact epilepsy prevalence. The Nordic nations are not only close geographically, but they also have a lot of similarities in their cultures, standards of living, and economy. Publicly subsidized, all-encompassing healthcare systems protect the Nordic region’s whole resident population. The resultant ever-growing aging population, early detection and diagnosis of epilepsy among the population, and various medical therapies have increased the market for epilepsy devices in Nordic Countries.
In Spain, epilepsy affects more than 4,000 children annually. Refractory epilepsy, or epilepsy that does not respond to medication, affects one in three people. Drug-resistant forms of epilepsy place a heavy strain on patients and their families. With recurring crises, underlying neurological conditions, medication side effects, and societal stigmatization, patients present major medical and social problems.
As a result, epilepsy treatments involving vagus nerve stimulation, deep brain stimulation, accelerometer, and neurostimulation will gain popularity throughout the anticipated period. Spain is also aiming to develop modern healthcare systems that will make available more affordable and effective solutions for the general people, increasing demand for epilepsy equipment.
COMPETITIVE INSIGHTS
Some of the key players include Philips NV, LivaNova PLC, NeuroPace Inc, Nihon Kohden Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
157 Pages
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Soaring Occurrences Of Epilepsy Globally
- 3.1.2. Onset Of Epilepsy In Elderly People
- 3.1.3. Mitigation Of Epilepsy Using Early Diagnosis
- 3.1.4. Surge In Post-traumatic Epilepsy With Rising Brain Injury Cases
- 3.2. Key Restraints
- 3.2.1. Misperceptions And Misinformation About Epilepsy
- 3.2.2. Shortage Of Neurology Specialists In The Healthcare System
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Epilepsy Devices Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 4.6. Value Chain Analysis
- 4.7. Key Buying Criteria
- 4.7.1. Comfort & Usability
- 4.7.2. Product Features
- 4.7.3. Confidentiality
- 4.8. Regulatory Framework
- 5. Market By Product Type
- 5.1. Conventional Devices
- 5.2. Wearable Devices
- 5.2.1. Watches
- 5.2.2. Bracelets
- 5.2.3. Camera Devices
- 5.2.4. Mattress Devices
- 5.2.5. Anti-suffocation Pillows
- 5.2.6. Other Wearable Devices
- 5.3. Implantable Devices
- 6. Market By Technology
- 6.1. Vagus Nerve Stimulation
- 6.2. Deep Brain Stimulation
- 6.2.1. Movement Disorders
- 6.2.2. Epilepsy
- 6.3. Accelerometry
- 6.4. Responsive Neurostimulation
- 7. Market By Detection & Prediction Devices Type
- 7.1. Electroencephalogram
- 7.2. Intracranial Eeg
- 7.3. Surface Electromyography
- 7.4. Electrocardiography
- 7.5. Video Detection Systems
- 7.6. Electrodermal Activity
- 7.7. Implanted Advisory Systems
- 7.8. Other Detection & Prediction Device Types
- 8. Market By End-user
- 8.1. Hospitals & Clinics
- 8.2. Neurology Centers
- 8.3. Home Care Settings
- 8.4. Other End-users
- 9. Geographical Analysis
- 9.1. Europe
- 9.1.1. Market Size & Estimates
- 9.1.2. Key Growth Enablers
- 9.1.3. Key Challenges
- 9.1.4. Key Players
- 9.1.5. Country Analysis
- 9.1.5.1. United Kingdom
- 9.1.5.2. Germany
- 9.1.5.3. France
- 9.1.5.4. Italy
- 9.1.5.5. Spain
- 9.1.5.6. Nordic Countries
- 9.1.5.7. Rest Of Europe
- 10. Competitive Landscape
- 10.1. Key Strategic Developments
- 10.1.1. Acquisitions
- 10.1.2. Product Launches & Developments
- 10.1.3. Partnerships
- 10.2. Company Profiles
- 10.2.1. Boston Scientific Corporation
- 10.2.2. Cadwell Industries Inc
- 10.2.3. Compumedics Limited
- 10.2.4. Drägerwerk Ag & Co Kgaa
- 10.2.5. Empatica Inc
- 10.2.6. Koninklijke Philips Nv
- 10.2.7. Livanova Plc
- 10.2.8. Medtronic Plc
- 10.2.9. Natus Medical Incorporated
- 10.2.10. Neuropace Inc
- 10.2.11. Neurosoft
- 10.2.12. Nihon Kohden Corporation
- 10.2.13. Shenzhen Mindray Bio-medical Electronics Co Ltd
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
